World’s first 3D printed drug approved - Prometheus IP

August 17, 2015by prometheusip0

The FDA has approved the world’s first 3D printed drug for the treatment of epilepsy. The new drug, Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy. The 3D technology allows Spritam (levetiracetam) to have higher manufacturing precision thus accommodating a higher dose almost upto 1000 mg in each tablet. As each drug will be completely uniform, it also means doses are more consistent.

Although the FDA has previously approved 3D-printed medical devices, this is the first time a 3D-printed product has been approved for use inside the human body.

Spritam is expected to be available in the first quarter of 2016.

prometheusip

Prometheus IP is a leading intellectual property service enterprise offering competent and economic Intellectual Property Rights (IPR) solutions which include Patents, Designs, Copyrights and Trademarks.

Hyderabad
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social
Prometheus IPHeadquarters
Prometheus Patent Services Pvt Ltd.
Plot No:438, SPR Arcade,
1st Floor, TNGO’s Colony Phase 2
Gachibowli, Hyderabad-500032
Telangana, India.
Our locationsWhere to find us?
https://www.prometheusip.com/wp-content/uploads/2020/01/footer-map.png
Get in touchPrometheus IP Social

Copyright Prometheus IP. All rights reserved.

Copyright Prometheus IP. All rights reserved.